Search
Tuesday 4 August 2015
  • :
  • :
Latest Update

Pre-Market News Report on: Opko Health. (NYSE:OPK), SYSCO (NYSE:SYY), Esperion Therapeutics (NASDAQ:ESPR), New York Community Bancorp, (NYSE:NYCB)

On Thursday, Opko Health Inc. (NYSE:OPK)’s shares declined -1.09% to $16.38.

Opko Health Inc. (OPK) may fit the first condition of being at or near its highs, but it does not fulfill the second. Those short Opko don’t seem to mind all that much, being that 44.92M shares are presently held short, constituting 67% of the float. That’s about a million more shares than last month, representing over $15M in capital spent on shorting the stock in one month, at least.

While shorting itself may tend to discourage some retail investors from taking a position, institutional investors in addition to company insiders are usually astute enough to know that for every short seller, there is a buyer of those shares on the other side. Close to 70% of Opko’s float is held by either insiders or institutions, and it is doubtful that any of those shares will be put on the open market any time soon. And even if some are, the company’s founder and CEO, Dr. Phillip Frost, is picking shares at the same pace that shortsellers are borrowing them to sell.

OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics. The company develops various solutions to diagnose, treat, and prevent various conditions, counting point-of-care tests, molecular diagnostics tests, laboratory developed tests, and proprietary pharmaceuticals and vaccines. Its products comprise 4Kscore test that measures the blood plasma levels of four different prostate-derived kallikrein proteins.

SYSCO Corporation(NYSE:SYY)’s shares dropped -0.52% to $36.06.

SYSCO Corporation (SYY) will host a live conference call and webcast to discuss its fourth quarter and fiscal 2015 financial results at 10 a.m. (Eastern), Monday, August 10. All interested parties are invited to listen online at investors.sysco.com. A replay of the webcast will be available online at investors.sysco.com shortly after the live webcast is completed.

Sysco Corporation, through its auxiliaries, markets and distributes a range of food and related products primarily to the foodservice or food-away-from-home industry. It operates in Broadline and SYGMA segments. The company distributes a line of frozen foods, such as meats, seafood, fully prepared entrees, fruits, vegetables, and desserts; a line of canned and dry foods; fresh meats; dairy products; beverage products; imported specialties; and fresh produce.

At the end of Thursday’s trade, Esperion Therapeutics Inc (NASDAQ:ESPR)‘s shares surged 2.83% to $64.25.

Esperion Therapeutics, Inc. (ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, recently declared that it will host its second annual analyst and investor day event and webcast for institutional investors and research analysts on Thursday, July 30 at 8:30 a.m. Eastern Time.

Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. Its products comprise ETC-1002, an oral molecule therapy that is in Phase 2b clinical trials to treat patients with hypercholesterolemia, in addition to to lower levels of LDL-cholesterol, and avoid various side effects associated with LDL-cholesterol lowering therapies.

New York Community Bancorp, Inc. (NYSE:NYCB), ended its Thursday’s trading session with 1.12% gain, and closed at $18.98.

New York Community Bancorp, Inc. (NYCB) will conduct a post-earnings conference call at 8:30 a.m. (EDT) on the same date, during which President and Chief Executive Officer Joseph R. Ficalora will talk about highlights of the Company’s second quarter 2015 performance, in addition to its business strategies. The conference call will be simultaneously webcast at ir.myNYCB.com and archived through 5:00 p.m. on August 19, 2015.

New York Community Bancorp, Inc. operates as a holding company for New York Community Bank and New York Commercial Bank that offer banking products and financial services in New York, New Jersey, Florida, Ohio, and Arizona. The company offers various deposit products that comprise checking and savings accounts, individual retirement accounts, certificates of deposit, NOW and money market accounts, and non-interest-bearing accounts.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

 




Leave a Reply

Your email address will not be published. Required fields are marked *